methyl 4-mercaptobutyrimidate and Astrocytoma, Grade IV

methyl 4-mercaptobutyrimidate has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dwarakanath, BS; Figueredo, R; Iznaga-Escobar, N; Jain, VK; Mathew, TL; Mishra, AK; Pérez-Rodríguez, R; Sharma, RK	1

Other Studies

1 other study(ies) available for methyl 4-mercaptobutyrimidate and Astrocytoma, Grade IV

Article	Year
Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies. Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:10 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Central Nervous System Neoplasms; Colonic Neoplasms; Cross-Linking Reagents; Disease Models, Animal; ErbB Receptors; Glioblastoma; Humans; Imidoesters; Immunoconjugates; Immunoglobulin G; Immunoradiometric Assay; Isothiocyanates; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Sodium Pertechnetate Tc 99m; Tissue Distribution; Tumor Cells, Cultured	2002

Article

Year

Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies.

Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:10

Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Central Nervous System Neoplasms; Colonic Neoplasms; Cross-Linking Reagents; Disease Models, Animal; ErbB Receptors; Glioblastoma; Humans; Imidoesters; Immunoconjugates; Immunoglobulin G; Immunoradiometric Assay; Isothiocyanates; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Sodium Pertechnetate Tc 99m; Tissue Distribution; Tumor Cells, Cultured

2002